These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18280527)

  • 1. Aldosterone: from biosynthesis to non-genomic action onto the proteome.
    Zöllner S; Hwang KH; Wilzewski B; Carapito C; Leize-Wagner E; Van Dorsselaer A; Bernhardt R
    Steroids; 2008 Oct; 73(9-10):966-72. PubMed ID: 18280527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension.
    Bureik M; Hübel K; Dragan CA; Scher J; Becker H; Lenz N; Bernhardt R
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):249-54. PubMed ID: 15134825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-adrenal mineralocorticoids and cardiovascular tissue.
    Slight SH; Joseph J; Ganjam VK; Weber KT
    J Mol Cell Cardiol; 1999 Jun; 31(6):1175-84. PubMed ID: 10371693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of aldosterone-induced differential receptor-independent protein patterns using 2D-electrophoresis and mass spectrometry.
    Böhmer S; Carapito C; Wilzewski B; Leize E; Van Dorsselaer A; Bernhardt R
    Biol Chem; 2006 Jul; 387(7):917-29. PubMed ID: 16913842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors.
    LaSala D; Shibanaka Y; Jeng AY
    Anal Biochem; 2009 Nov; 394(1):56-61. PubMed ID: 19622340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
    McCormick SD; Regish A; O'Dea MF; Shrimpton JM
    Gen Comp Endocrinol; 2008 May; 157(1):35-40. PubMed ID: 18462736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension.
    Hakki T; Hübel K; Waldmann H; Bernhardt R
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):120-8. PubMed ID: 21193036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone synthase inhibitors: pharmacological and clinical aspects.
    Jansen PM; van den Meiracker AH; Jan Danser AH
    Curr Opin Investig Drugs; 2009 Apr; 10(4):319-26. PubMed ID: 19337952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular identity and gene expression of aldosterone synthase cytochrome P450.
    Okamoto M; Nonaka Y; Takemori H; Doi J
    Biochem Biophys Res Commun; 2005 Dec; 338(1):325-30. PubMed ID: 16105656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interacting influence of potassium and polychlorinated biphenyl on cortisol and aldosterone biosynthesis.
    Li LA; Lin TC
    Toxicol Appl Pharmacol; 2007 May; 220(3):252-61. PubMed ID: 17350062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
    Haller J; Mikics E; Makara GB
    Front Neuroendocrinol; 2008 May; 29(2):273-91. PubMed ID: 18054070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that corticosterone is not an obligatory intermediate in aldosterone biosynthesis in the rat adrenal.
    Häusler A; Monnet G; Borer C; Bhatnagar AS
    J Steroid Biochem; 1989; 34(1-6):567-70. PubMed ID: 2533953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis.
    Voets M; Antes I; Scherer C; Müller-Vieira U; Biemel K; Marchais-Oberwinkler S; Hartmann RW
    J Med Chem; 2006 Apr; 49(7):2222-31. PubMed ID: 16570918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a ligand-based theoretical approach to derive conversion paths and ligand conformations in CYP11B2-mediated aldosterone formation.
    Roumen L; Van Hoof B; Pieterse K; Hilbers PA; Custers EM; Plate R; De Gooyer M; Beugels IP; Emmen JM; Leysen D; Smits JF; Ottenheijm HC; Hermans JJ
    J Comput Chem; 2011 Aug; 32(11):2441-8. PubMed ID: 21598279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
    Heim R; Lucas S; Grombein CM; Ries C; Schewe KE; Negri M; Müller-Vieira U; Birk B; Hartmann RW
    J Med Chem; 2008 Aug; 51(16):5064-74. PubMed ID: 18672861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quick glance at rapid aldosterone action.
    Lösel R; Schultz A; Wehling M
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):137-41. PubMed ID: 15134812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nongenotropic aldosterone effects and the EGFR: interaction and biological relevance.
    Grossmann C; Gekle M
    Steroids; 2008 Oct; 73(9-10):973-8. PubMed ID: 18249428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.